In all, 14 patients had isolated new onset deep venous thrombosis (DVT), eight patients had isolated pulmonary emboli (PE) and 4 patients had both DVT and PE upon study entry (Table 1). 1 TABLE Patient demographics. At the completion of 3 months of therapy, 63.6% (14 of 22) had a CR and 36.4% (8 of 22) had a PR with no patients having stable disease (Figure 1). Importantly, there were no patients who experienced a new VTE, which equates to 100% successful VTE secondary prophylaxis. [Extracted from the article]